The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Paraneoplastic anti– N ‐methyl‐ D ‐aspartate receptor encephalitis associated with ovarian teratoma
Open accessAbstract
OBJECTIVE: To report the autoantigens of a new category of treatment-responsive paraneoplastic encephalitis. METHODS: Analysis of clinical features, neuropathological findings, tumors, and serum/cerebrospinal fluid antibodies using rat tissue, neuronal cultures, and HEK293 cells expressing subunits of the N-methyl-D-aspartate receptor (NMDAR). RESULTS: Twelve women (14-44 years) developed prominent psychiatric symptoms, amnesia, seizures, frequent dyskinesias, autonomic dysfunction, and decreased level of consciousness often requiring ventilatory support. All had serum/cerebrospinal fluid antibodies that predominantly immunolabeled the neuropil of hippocampus/forebrain, in particular the cell surface of hippocampal neurons, and reacted with NR2B (and to a lesser extent NR2A) subunits of the NMDAR. NR2B binds glutamate and forms heteromers (NR1/NR2B or NR1/NR2A/NR2B) that are preferentially expressed in the adult hippocampus/forebrain. Expression of functional heteromers (not single subunits) was required for antibody binding. Eleven patients had teratoma of the ovary (six mature) and one a mature teratoma in the mediastinum; five of five tumors examined contained nervous tissue that strongly expressed NR2 subunits and reacted with patients' antibodies. Tumor resection and immunotherapy resulted in improvement or full recovery of eight of nine patients (paralleled by decreased antibody titers); two of three patients without tumor resection died of neurological deterioration. Autopsies showed extensive microgliosis, rare T-cell infiltrates, and neuronal degeneration predominantly involving, but not restricted to, the hippocampus. INTERPRETATION: Antibodies to NR2B- and NR2A-containing heteromers of the NMDAR associate with a severe but treatment-responsive encephalitis. Our findings provide a diagnostic test and suggest a model of autoimmune NMDAR-related encephalitis with broad implications for other immune-mediated disorders of memory, behavior, and cognition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Preliminary studies suggested the target epitopes were located in extracellular regions of NR1–NR2B NMDA receptors.5”
From Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies (2008) · cites this paper as [5]
In the citing paper
“We recently identified a disorder, designated anti-NMDA-receptor encephalitis, that associates with antibodies against NR1–NR2 heteromers and results in a characteristic neuropsychiatric syndrome.5”
From Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies (2008) · cites this paper as [5]
In the citing paper
“The first patients identified were young women with ovarian teratoma who presented with psychosis or memory problems, rapidly progressing to multiple neurological deficits requiring prolonged intensive care support.”
From Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies (2008) · cites this paper as [5]
In the citing paper
“Serum and CSF were tested for antibodies against the NMDA receptor,5 and considered positive if three immunohistochemical criteria were fulfilled (figure 1).”
From Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies (2008) · cites this paper as [5]
In the citing paper
“Despite the severity of the disorder, patients often recovered after tumour removal and immunotherapy, suggesting an immune-mediated pathogenesis.”
From Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies (2008) · cites this paper as [5]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Monyer, H., Burnashev, N., Laurie, D. J., Sakmann, B., & Seeburg, P. H. (1994) · Neuron · doi:10.1016/0896-6273(94)90210-0 · Cited by 3,535
Gultekin, S. H. (2000) · Brain · doi:10.1093/brain/123.7.1481 · Cited by 1,110
Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients
Graus, F. (2001) · Brain · doi:10.1093/brain/124.6.1138 · Cited by 891
DeGiorgio, L. A., Konstantinov, K. N., Lee, S. C., Hardin, J., Volpe, B. T., & Diamond, B. (2001) · Nature Medicine · doi:10.1038/nm1101-1189 · Cited by 798
Clinical analysis of anti-Ma2-associated encephalitis
Dalmau, J. O. (2004) · Brain · doi:10.1093/brain/awh203 · Cited by 776
Antigen unmasking on formalin‐fixed, paraffin‐embedded tissue sections
Cattoretti, G., Pileri, S. A., Parravicini, C., Becker, M. H. G., Poggi, S., Bifulco, C. B., Key, G., D'Amato, L., Sabattini, E., Feudale, E. A. A., et al. (1993) · The Journal of Pathology · doi:10.1002/path.1711710205 · Cited by 721
Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma
Vitaliani, R., Mason, W. P., Ances, B. M., Zwerdling, T., Jiang, Z., & Dalmau, J. O. (2005) · Annals of Neurology · doi:10.1002/ana.20614 · Cited by 604
Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates
Ances, B. M., Vitaliani, R., Taylor, R. A., Liebeskind, D. S., Voloschin, A. D., Houghton, D. J., Galetta, S. L., Dichter, M. A., Alavi, A. A., Rosenfeld, M. R., et al. (2005) · Brain · doi:10.1093/brain/awh526 · Cited by 486
Laube, B., Hirai, H., Sturgess, M., Betz, H., & Kuhse, J. (1997) · Neuron · doi:10.1016/s0896-6273(00)81249-0 · Cited by 476
Wenzel, A., Fritschy, J., Möhler, H., & Benke, D. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68020469.x · Cited by 442
Cited by
Sorted by citations
Items 501–600 of 1,000
Diagnostic and Pathogenic Significance of Glutamate Receptor Autoantibodies
Pleasure, D. (2008) · Archives of Neurology · doi:10.1001/archneur.65.5.589 · Cited by 36
Punja, M., Pomerleau, A. C., Devlin, J. J., Morgan, B., Schier, J. G., & Schwartz, M. D. (2013) · Clinical Toxicology · doi:10.3109/15563650.2013.829235 · Cited by 36
Morgan, A., Li, Y., Thompson, N. R., Milinovich, A., Abbatemarco, J., Cohen, J. A., Ontaneda, D., Punia, V., Rae-Grant, A. D., Galioto, R., et al. (2024) · Neurology · doi:10.1212/wnl.0000000000208019 · Cited by 35
NMDA receptor autoantibodies primarily impair the extrasynaptic compartment
Jamet, Z., Mergaux, C., Meras, M., Bouchet, D., Villega, F., Kreye, J., Prüß, H., & Groc, L. (2024) · Brain · doi:10.1093/brain/awae163 · Cited by 36
Neuro-immunobiology and treatment assessment in a mouse model of anti-NMDAR encephalitis
Maudes, E., Planagumà, J., Marmolejo, L., Radosevic, M., Serafim, A. B., Aguilar, E., Sindreu, C. B., Landa, J., García‐Serra, A., Mannara, F., et al. (2024) · Brain · doi:10.1093/brain/awae410 · Cited by 38
Autoantibody-Associated Movement Disorders
Mohammad, S. S., Ramanathan, S., Brilot, F., & Dale, R. C. (2013) · Neuropediatrics · doi:10.1055/s-0033-1358603 · Cited by 35
Childhood Anti-NMDA Receptor Encephalitis
Suthar, R., Saini, A. G., Sankhyan, N., Sahu, J. K., & SINGHI, P. D. (2016) · The Indian Journal of Pediatrics · doi:10.1007/s12098-015-1988-8 · Cited by 35
GABA and Glutamate: Their Transmitter Role in the CNS and Pancreatic Islets
Hampe, C. S., Mitoma, H., & Manto, M. U. (2018) · InTech eBooks · doi:10.5772/intechopen.70958 · Cited by 38
A review of EEG in anti-NMDA receptor encephalitis
Freund, B. E., & Ritzl, E. K. (2019) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2019.03.010 · Cited by 34
Boesen, M. S., Born, A. P., Lydolph, M. C., Blaabjerg, M., & Børresen, M. L. (2019) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2019.03.007 · Cited by 35
Elevated serum anti-NMDA receptor antibody levels in first-episode patients with schizophrenia
Tong, J., Huang, J., Luο, X., Chen, S., Cui, Y., An, H., Xiu, M., Tan, S., Wang, Z., Yuan, Y., et al. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.06.017 · Cited by 35
Anti-NMDA receptor encephalitis: a case study and illness overview
Ford, B., McDonald, A., & Srinivasan, S. (2019) · Drugs in Context · doi:10.7573/dic.212589 · Cited by 36
Differences and diversity of autoimmune encephalitis in 77 cases from a single tertiary care center
Saraya, A. W., Worachotsueptrakun, K., Vutipongsatorn, K., Sonpee, C., & Hemachudha, T. (2019) · BMC Neurology · doi:10.1186/s12883-019-1501-5 · Cited by 35
Neurological complications of pediatric cancer
Armstrong, C., & Sun, L. R. (2020) · Cancer and Metastasis Reviews · doi:10.1007/s10555-020-09847-0 · Cited by 36
Jiang, X., Song, L., Zhang, L., Liu, X., Lin, M., Blümcke, I., Piao, Y.-S., Zhou, D., & Li, J. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-00999-2 · Cited by 35
Clinical outcomes of pediatric Anti-NMDA receptor encephalitis
Shim, Y., Kim, S. Y., Kim, H., Hwang, H. Y., Chae, J., Choi, J., Kim, K. J., Yum, M., Ko, T. S., Kim, Y. O., et al. (2020) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2020.10.001 · Cited by 35
Gastaldi, V. D., Wilke, J. B. H., Weidinger, C. A., Walter, C., Barnkothe, N., Teegen, B., Luessi, F., STÖCKER, W., Lühder, F., Begemann, M., et al. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2022.10.016 · Cited by 36
Ramberger, M., Peschl, P., Schanda, K., Irschick, R., Höftberger, R., Deisenhammer, F., Rostasy, K. M., Berger, T., Dalmau, J. O., & Reindl, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0122037 · Cited by 34
Cell-Mediated Immune Responses in Paraneoplastic Neurological Syndromes
Zaborowski, M. P., & Michalak, S. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/630602 · Cited by 35
Detection methods for neural autoantibodies
Waters, P. J., Pettingill, P., & Lang, B. (2016) · Handbook of clinical neurology · doi:10.1016/b978-0-444-63432-0.00009-8 · Cited by 36
Autoimmune Movement Disorders: a Clinical and Laboratory Approach
Honorat, J. A., & McKeon, A. B. (2017) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-017-0709-2 · Cited by 36
Weissert, R. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00336 · Cited by 37
Autoimmune encephalitis-associated epilepsy
Steriade, C., Bauer, J., & Bien, C. G. (2025) · Nature Reviews Neurology · doi:10.1038/s41582-025-01089-4 · Cited by 34
Pseudopseudoseizures: Conditions That May Mimic Psychogenic Non-Epileptic Seizures
Caplan, J. P., Binius, T., Lennon, V. A., Pittock, S. J., & Rao, M. S. (2011) · Psychosomatics · doi:10.1016/j.psym.2011.08.004 · Cited by 34
Coherent Somatic Mutation in Autoimmune Disease
Ross, K. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101093 · Cited by 34
Ju, P., & Cui, D. (2016) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmv135 · Cited by 33
Paraneoplastic disorders of the central and peripheral nervous systems
Didelot, A., & Honnorat, J. (2013) · Handbook of clinical neurology · doi:10.1016/b978-0-7020-4088-7.00078-x · Cited by 36
Anti-NMDA Receptor antibody encephalitis with concomitant detection of Varicella zoster virus
Solis, N. P., Salazar, L., & Hasbun, R. (2016) · Journal of Clinical Virology · doi:10.1016/j.jcv.2016.08.292 · Cited by 34
Clinical utility of magnetic resonance imaging in first-episode psychosis
Falkenberg, I., Benetti, S., Raffin, M., Wuyts, P., Pettersson‐Yeo, W., Dazzan, P., Morgan, K. D., Murray, R. M., Marques, T. R., David, A. S., et al. (2017) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.116.195834 · Cited by 34
Autoantibody-Mediated Encephalitis
Wandinger, K., Leypoldt, F., & Junker, R. (2018) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2018.0666 · Cited by 34
Kersten, M., Rabbe, T., Blome, R., Porath, K., Sellmann, T., Bien, C. G., Köhling, R., & Kirschstein, T. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00586 · Cited by 34
Pan, H., Steixner-Kumar, A. A., Seelbach, A., Deutsch, N. R., Ronnenberg, A., Tapken, D., von Ahsen, N., Mitjans, M., Worthmann, H., Trippe, R., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0672-1 · Cited by 36
Neurocritical care for Anti-NMDA receptor encephalitis
Lin, K., & Lin, J.-J. (2020) · Biomedical Journal · doi:10.1016/j.bj.2020.04.002 · Cited by 34
Kelleher, E., McNamara, P., Dunne, J., Fitzmaurice, B., Heron, E. A., Whitty, P., Walsh, R. A., Mooney, C., Hogan, D., Conlon, N. P., et al. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2019.11.023 · Cited by 34
Clinical Features and Treatment Outcomes of Seronegative Pediatric Autoimmune Encephalitis
Lee, S., Kim, H. D., Lee, J. S., Kang, H., & Kim, S. H. (2021) · Journal of Clinical Neurology · doi:10.3988/jcn.2021.17.2.300 · Cited by 35
CSF-Neurofilament Light Chain Levels in NMDAR and LGI1 Encephalitis: A National Cohort Study
Nissen, M. S., Ryding, M., Nilsson, A. C., Madsen, J. S., Olsen, D. A., Halekoh, U., Lydolph, M. C., Illés, Z., & Blaabjerg, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.719432 · Cited by 34
Update and new insights in encephalitis
Mailles, A., Stahl, J. ‐., & Bloch, K. C. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.05.002 · Cited by 35
Pathogenicity of Antibodies against NMDA Receptor: Molecular Insights into Autoimmune Psychosis
Jézéquel, J., Johansson, E. M., Leboyer, M., & Groc, L. (2018) · Trends in Neurosciences · doi:10.1016/j.tins.2018.05.002 · Cited by 35
Chang, H., Ma, J., Feng, K., Feng, N., Wang, X., Sun, J., Guo, T., Wei, Y., Xu, Y., Wang, H., et al. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02841-7 · Cited by 33
Braczkowski, M., Soszyński, D., Sierakowska, A., Braczkowski, R., Kufel, K. M., & Labuz-Roszak, B. M. (2023) · Diagnostics · doi:10.3390/diagnostics13152589 · Cited by 35
A Case of Anti-NMDA Receptor Encephalitis Treated with ECT
Jones, K. C., Schwartz, A. C., Hermida, A. P., & Kahn, D. A. (2015) · Journal of Psychiatric Practice · doi:10.1097/pra.0000000000000100 · Cited by 33
Epileptic Encephalitis: The Role of the Innate and Adaptive Immune System
Bauer, J., Vezzani, A., & Bien, C. G. (2012) · Brain Pathology · doi:10.1111/j.1750-3639.2012.00580.x · Cited by 34
McKeon, A. B., Ahlskog, J. E., Britton, J. A., Lennon, V. A., & Pittock, S. J. (2009) · Archives of Neurology · doi:10.1001/archneurol.2008.556 · Cited by 33
Ran, Y., Wang, L., Zhang, F., Ao, R., Dong, Z., & Yu, S. (2017) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2017.02.016 · Cited by 32
Mitra, A. D., & Afifya, A. (2018) · Autopsy and Case Reports · doi:10.4322/acr.2018.019 · Cited by 33
Monoclonal antibodies from a patient with anti‐ NMDA receptor encephalitis
Sharma, R., Al‐Saleem, F. H., Panzer, J. A., Lee, J., Puligedda, R. D., Felicori, L. F., Kattala, C. D., Rattelle, A., Ippolito, G. C., Cox, R. H., et al. (2018) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.592 · Cited by 33
Cainelli, E., Nosadini, M., Sartori, S., & Suppiej, A. (2018) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acy088 · Cited by 33
Ovarian Teratomas in Women With Anti-N-methyl-D-Aspartate Receptor Encephalitis
Nolan, A., Buza, N., Margeta, M., & Rabban, J. T. (2019) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000001249 · Cited by 33
Tanaka, K., Kawamura, M., Sakimura, K., & Kato, N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144941 · Cited by 33
Cullen, A. E., Palmer-Cooper, E. C., Hardwick, M., Vaggers, S., Crowley, H., Pollak, T. A., & Lennox, B. (2020) · The Lancet Psychiatry · doi:10.1016/s2215-0366(20)30432-6 · Cited by 34
Gardoni, F., Stanic, J., Scheggia, D., Benussi, A., Borroni, B., & Luca, M. D. (2021) · Cells · doi:10.3390/cells10010077 · Cited by 35
Katz, J., Owusu, K. A., Nussbaum, I., Beekman, R. B., DeFilippo, N., Gilmore, E. J., Hirsch, L. J., Cervenka, M. C., & Maciel, C. B. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10040881 · Cited by 33
Immunotherapy in autoimmune encephalitis
Trewin, B. P., Freeman, I., Ramanathan, S., & Irani, S. R. (2022) · Current Opinion in Neurology · doi:10.1097/wco.0000000000001048 · Cited by 34
Verhelst, H., Verloo, P., Dhondt, K., Paepe, B. D., Menten, B., Dalmau, J. O., & Coster, R. V. (2010) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2010.07.004 · Cited by 33
Okubo, R., Okada, M., & Motomura, E. (2024) · Biomolecules · doi:10.3390/biom14091128 · Cited by 37
Nicolle, D. C. M., & Moses, J. L. (2018) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acy005 · Cited by 32
An Overview of Autoimmune and Paraneoplastic Encephalitides
Bradshaw, M., & Linnoila, J. (2018) · Seminars in Neurology · doi:10.1055/s-0038-1660821 · Cited by 32
Management of Autoimmune Encephalitis: An Observational Monocentric Study of 38 Patients
Macher, S., Zimprich, F., Simoni, D. D., Höftberger, R., & Rommer, P. S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02708 · Cited by 32
Muñiz-Castrillo, S., Ambati, A., Dubois, V., Vogrig, A., Joubert, B., Rogemond, V., Picard, G., Lin, L., Fabien, N., Mignot, E., et al. (2020) · Journal of Neurology · doi:10.1007/s00415-020-09782-8 · Cited by 28
Wang, H., & Xiao, Z. (2020) · BioMed Research International · doi:10.1155/2020/7506590 · Cited by 32
Autoimmune encephalitis in children and adolescents
Bien, C. G., & Bien, C. (2020) · Neurological Research and Practice · doi:10.1186/s42466-019-0047-8 · Cited by 32
Successful Treatment of Acute Autoimmune Limbic Encephalitis With Negative VGKC and NMDAR Antibodies
Modoni, A., Masciullo, M., Spinelli, P., Marra, C., Tartaglione, T., Andreetta, F., Tonali, P. A., & Silvestri, G. (2009) · Cognitive and Behavioral Neurology · doi:10.1097/wnn.0b013e318190d195 · Cited by 32
F-18 Fluorodeoxyglucose PET/CT Findings in a Case of Anti-NMDA Receptor Encephalitis
Mohr, B. C., & Minoshima, S. (2010) · Clinical Nuclear Medicine · doi:10.1097/rlu.0b013e3181db4d4a · Cited by 32
Anti–N-Methyl- d -Aspartate Receptor Encephalitis
Thomas, A. A., Rauschkolb, P. K., Gresa‐Arribas, N., Schned, A. R., Dalmau, J. O., & Fadul, C. E. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.3205 · Cited by 32
Neuronal central nervous system syndromes probably mediated by autoantibodies
Chefdeville, A., Honnorat, J., Hampe, C. S., & Desestret, V. (2016) · European Journal of Neuroscience · doi:10.1111/ejn.13212 · Cited by 31
Electroconvulsive therapy can improve psychotic symptoms in anti‐NMDA‐receptor encephalitis
Matsumoto, T., Matsumoto, K., Kobayashi, T., & Kato, S. (2012) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2012.02324.x · Cited by 31
Anti-NMDA receptor encephalitis associated with ictal asystole
Lee, M. W., Lawn, N. D., Prentice, D. A., & Chan, J. (2011) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2011.03.024 · Cited by 31
Bauer, J., & Bien, C. G. (2009) · Seminars in Immunopathology · doi:10.1007/s00281-009-0176-1 · Cited by 31
Immune-mediated cerebellar ataxias: from bench to bedside
Mitoma, H., Manto, M. U., & Hampe, C. S. (2017) · Cerebellum & Ataxias · doi:10.1186/s40673-017-0073-7 · Cited by 32
Bygrave, A. M., Kilonzo, K., Kullmann, D. M., Bannerman, D. M., & Kätzel, D. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00835 · Cited by 35
Pérez, C. A., Agyei, P., Gogia, B., Harrison, R. A., & Samudralwar, R. D. (2019) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2019.577124 · Cited by 31
Detection of anti-ganglioside antibodies in Guillain-Barre syndrome
Zhu, W., Li, K., Cui, T., & Yan, Y. (2021) · Annals of Translational Medicine · doi:10.21037/atm-20-2285 · Cited by 31
Anti-N-Methyl-D-Aspartate Receptor Encephalitis and Its Anesthetic Implications
Pryzbylkowski, P., Dunkman, W. J., Liu, R., & Chen, L. (2011) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e31822b8a7d · Cited by 31
Paraneoplastic Neurological Syndromes: General Treatment Overview
Viaccoz, A., & Honnorat, J. (2013) · Current Treatment Options in Neurology · doi:10.1007/s11940-013-0220-2 · Cited by 31
Llorens, V., Gabilondo, I., Gómez‐Esteban, J. C., Agundez, M., Mendibe, M., Bergara, J. C., Ciordia, R., Saiz, A., & Zarranz, J. J. (2010) · Journal of Neurology · doi:10.1007/s00415-010-5546-z · Cited by 31
Anti-NMDA Receptor Encephalitis, Autoimmunity, and Psychosis
Kayser, M. S., & Dalmau, J. O. (2016) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.140405 · Cited by 32
Encephalitis associated with antibodies against the NMDA receptor
Guasp, M., & Dalmau, J. O. (2018) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2018.05.020 · Cited by 31
Cavaliere, E., Nosadini, M., Pelizza, M. F., Ventura, G., Toldo, I., & Sartori, S. (2019) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2019.03.011 · Cited by 31
Outcome and Sequelae of Autoimmune Encephalitis
Kvam, K. A., Stahl, J. ‐., Chow, F. C., Soldatos, A. G., Tattevin, P., Sejvar, J. J., & Mailles, A. (2024) · Journal of Clinical Neurology · doi:10.3988/jcn.2023.0242 · Cited by 30
Wang, H., Xie, C., Deng, B., Ding, J., Li, N., Kou, Z., Jin, M., He, J., Wang, Q., Wen, H., et al. (2024) · Nature Structural & Molecular Biology · doi:10.1038/s41594-024-01387-3 · Cited by 33
In vitro neuronal network activity in NMDA receptor encephalitis
Jantzen, S., Ferrea, S., Wach, C., Quasthoff, K. N., Illes, S., Scherfeld, D., Hartung, H., Seitz, R. J., & Dihné, M. (2013) · BMC Neuroscience · doi:10.1186/1471-2202-14-17 · Cited by 30
Early and persistent ‘extreme delta brush’ in a patient with anti-NMDA receptor encephalitis
VanHaerents, S. A., Stillman, A., Inoa, V., Searls, D. E., & Herman, S. T. (2014) · Epilepsy & Behavior Case Reports · doi:10.1016/j.ebcr.2014.01.002 · Cited by 30
Ankeny, R. A. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511762154.013 · Cited by 30
Germ Cell Tumors of the Female Genital Tract
Nogales, F. F., & Schuldt, M. (2017) · Springer eBooks · doi:10.1007/978-3-662-53775-6_6 · Cited by 30
Höftberger, R., & Lassmann, H. (2017) · Handbook of clinical neurology · doi:10.1016/b978-0-12-802395-2.00020-1 · Cited by 30
Gu, J., Jin, T., Li, Z., Chen, H., Xia, H., Xu, X., & Gui, Y. (2021) · Molecular Immunology · doi:10.1016/j.molimm.2020.12.034 · Cited by 30
Andrzejak, E., Rabinovitch, E., Kreye, J., Prüss, H., Rosenmund, C., Ziv, N. E., Garner, C. C., & Ackermann, F. (2022) · Journal of Neuroscience · doi:10.1523/jneurosci.1689-21.2022 · Cited by 30
Gaspard, N. (2016) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000000272 · Cited by 30
Goodfellow, J. A., & Mackay, G. A. (2019) · The Journal of the Royal College of Physicians of Edinburgh · doi:10.4997/jrcpe.2019.407 · Cited by 30
Paraneoplastic Neurologic Disorders in Children
Wells, E. M., & Dalmau, J. O. (2010) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-010-0169-4 · Cited by 30
Anti-NMDA receptor encephalitis during pregnancy
Ito, Y., Abe, T., Tomioka, R., Komori, T., & Araki, N. (2010) · Rinsho Shinkeigaku · doi:10.5692/clinicalneurol.50.103 · Cited by 30
Potential side effect of propofol and sevoflurane for anesthesia of anti-NMDA-R encephalitis
Lapébie, F.-X., Kennel, C., Magy, L., Projetti, F., Honnorat, J., Pichon, N., Vignon, P., & François, B. (2014) · BMC Anesthesiology · doi:10.1186/1471-2253-14-5 · Cited by 31
Kalev‐Zylinska, M. L., Symes, W., Little, K. C., Sun, P., Wen, D., Qiao, L., Young, D., During, M. J., & Barber, P. A. (2013) · Stroke · doi:10.1161/strokeaha.113.001235 · Cited by 30
Morris, N. A., Kaplan, T., Linnoila, J., & Cho, T. A. (2015) · Journal of NeuroVirology · doi:10.1007/s13365-015-0364-9 · Cited by 31
Status epilepticus suspected autoimmune: Neuronal surface antibodies and main clinical features
Suga, H., Yanagida, A., Kanazawa, N., Ohara, H., Kitagawa, T., Hayashi, M., Onozawa, Y., Nagata, N., Kaneko, J., Kitamura, E., et al. (2021) · Epilepsia · doi:10.1111/epi.17055 · Cited by 29
Rituximab Used Successfully in the Treatment of Anti-NMDA Receptor Encephalitis
Ikeguchi, R., Shibuya, K., Akiyama, S., Hino, S., Kubo, H., Takeda, T., Shibata, N., & Yamamoto, K. (2012) · Internal Medicine · doi:10.2169/internalmedicine.51.6874 · Cited by 29
Focal seizures in children with anti-NMDA receptor antibody encephalitis
Sands, T. T., Nash, K. B., Tong, S., & Sullivan, J. E. (2015) · Epilepsy Research · doi:10.1016/j.eplepsyres.2015.02.010 · Cited by 29
Lebon, S., Mayor-Dubois, C., Popea, I., Poloni, C. B., Selvadoray, N., Gumy, A., & Roulet‐Perez, E. (2012) · Journal of Child Neurology · doi:10.1177/0883073812438099 · Cited by 29
Kim, S. Y., Choi, S. A., Ryu, H. W., Kim, H., Lim, B. C., Hwang, H. Y., Chae, J., Choi, J., Kim, K. J., Hwang, Y. S., et al. (2014) · Journal of Epilepsy Research · doi:10.14581/jer.14012 · Cited by 29
Visual dysfunction, but not retinal thinning, following anti-NMDA receptor encephalitis
Brandt, A. U., Oberwahrenbrock, T., Mikolajczak, J., Zimmermann, H. G., Prüß, H., Paul, F., & Finke, C. (2016) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000198 · Cited by 29
Metadata
- Authors
- Dalmau, J., Tüzün, E., Wu, H., Masjuan, J., Rossi, J. E., Voloschin, A., Baehring, J. M., Shimazaki, H., Koide, R., King, D., Mason, W., Sansing, L. H., Dichter, M. A., Rosenfeld, M. R., & Lynch, D. R.
- Affiliations
- University of Pennsylvania (US)
- Augusta University (US)
- Yale University (US)
- Jichi Medical University (JP)
- Tokyo Metropolitan Neurological Hospital (JP)
- Children's Hospital of Pittsburgh (US)
- Princess Margaret Cancer Centre (CA)
- Corresponding author
- Dalmau, Josep
- ORCID
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2007-01
- Volume
- 61
- Issue
- 1
- Pages
- 25-36
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- PMC
- PMC2430743
- OpenAlex
- W2114398221
- Cited by
- 2,492
- References
- 37
- Citations by year
- 2026: 105 · 2025: 122 · 2024: 142 · 2023: 135 · 2022: 168 · 2021: 190 · 2020: 158 · 2019: 179 · 2018: 128 · 2017: 152 · 2016: 158 · 2015: 145 · 2014: 129 · 2013: 143 · 2012: 113
- FWCI
- 47.94
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Annals of Neurology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (R01CA089054, R01CA107192)
- National Institute of Neurological Disorders and Stroke (R01NS045986)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Autoimmune Neurological Disorders and Treatments
- Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
- Health Sciences › Medicine › Clinical Neurology › Myasthenia Gravis and Thymoma
- Keywords
- paraneoplastic encephalitis, anti-NMDA receptor encephalitis, ovarian teratoma, NMDA receptor subunits, NR2B, NR2A, autoantibodies, hippocampal neurons, autoimmune encephalitis, tumor resection, immunotherapy, microglial activation, neurodegeneration, psychiatric symptoms, amnesia, seizures
- MeSH terms
- Adolescent, Adult, Animals, Antibodies, Dissection, Encephalitis, Female, Humans, Immunohistochemistry, Immunosuppressive Agents, Magnetic Resonance Imaging, Male, Neurons, Ovarian Neoplasms, Teratoma, Transfection, Gene Expression Regulation, Neoplastic, Receptors, N-Methyl-D-Aspartate, Treatment Outcome, Rats, Wistar, Protein Subunits, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
